Research News and Research

RSS

House Republicans unveil partial list of budget cuts, advance plan to offer amendments to 'defund' health law

The National Journal reports on speculation that the GOP decision to advance a "clean" continuing resolution may signal that the Republican leadership is trying to move away from the partisan fight surrounding efforts to repeal the health law.

10 Feb 2011

New model of dementia care reduces emergency department visits, hospitalizations

An innovative model of dementia care developed by researchers at the Indiana University School of Medicine and the Regenstrief Institute significantly reduces emergency department visits and hospitalizations, and encourages use of medications that are not harmful to older brains. The result is improved health for older adults and their family caregivers and lower healthcare costs, according to a paper evaluating the model in real world use.

10 Feb 2011

Medivir initiates phase 1a clinical trial of TMC649128 for chronic HCV infection

Medivir AB, the emerging research-based specialty pharmaceutical company focused on infectious diseases, today announces the start of a phase 1a clinical trial with TMC649128 intended for the treatment of chronic hepatitis C virus infection.

10 Feb 2011

College health plans must comply with health law's 'central provisions'

The Department of Health and Human Services made clear Wednesday that the nation's colleges and universities would not be exempt from the requirements of the health overhaul.

10 Feb 2011

Global Health Consortium to support development of vaccines to control dengue fever

The International Vaccine Institute today announced the launch of the Dengue Vaccine Initiative, in collaboration with the Sabin Vaccine Institute, the Johns Hopkins University, and the World Health Organization, to support development of vaccines to control dengue fever, a widespread and expanding hemorrhagic fever that is endemic in most tropical and subtropical regions of the world.

10 Feb 2011

Genta initiates new Phase 2 clinical trial of tesetaxel in patients with advanced prostate cancer

Genta Incorporated today announced that the Company has initiated a new Phase 2 clinical trial of tesetaxel in patients with advanced prostate cancer. Tesetaxel, the leading oral taxane in clinical development, will be evaluated for its use as both first- and second-line chemotherapy.

10 Feb 2011

Guide designed to help hospitals reduce variation in care

The American Hospital Association has released a guide to help hospitals and health care systems reduce inappropriate variation in areas such as end-of-life care, imaging, emergency services and obstetrics.

10 Feb 2011

Researchers find significant association between childhood physical abuses, peptic ulcers

Victims of childhood physical abuse are more than twice as likely to develop ulcers than people who were not abused as children, according to a new study from researchers at the University of Toronto.

10 Feb 2011

Analyst offers prediction about Medicare advantage plans

Initial 2012 reimbursement rates for Medicare Advantage plans should be roughly flat, which tops the consensus expectation of a 2 percent drop, according to Citi analyst Carl McDonald. McDonald said Tuesday in a research note the rates will be hurt by cuts from the health care overhaul, but he also thinks they will benefit from an adjustment to prior estimates.

10 Feb 2011

NeoGenomics fourth quarter revenue increases 12% to $8.8 million

NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services, today reported its results for the fourth quarter 2010 and fiscal year ended December 31, 2010.

10 Feb 2011

First Edition: February 10, 2011

Today's headlines include news about how the legal skirmishes surrounding the health overhaul are heating up.

10 Feb 2011

Momenta reports fourth quarter 2010 net income of $36.3M vs. $14.7M net loss for fourth quarter 2009

Momenta Pharmaceuticals, Inc., a biotechnology company specializing in the characterization and engineering of complex drugs, today reported its financial results for the fourth quarter and year ended December 31, 2010.

10 Feb 2011

Full genetic blueprint of multiple prostate tumors laid bare

For the first time, researchers have laid bare the full genetic blueprint of multiple prostate tumors, uncovering alterations that have never before been detected and offering a deep view of the genetic missteps that underlie the disease. The study, made possible by key advances in whole genome sequencing and analysis, points to several new prostate cancer genes and a critical category of genomic changes as important drivers of prostate cancer growth.

10 Feb 2011

LabCorp fourth quarter net earnings decrease to $131.8 million

Laboratory Corporation of America® Holdings today announced results for the quarter and year ended December 31, 2010. These results include the operations of Genzyme Genetics for the month of December.

10 Feb 2011

TMJ Medical receives FDA postmarket surveillance study order

TMJ Medical acknowledged Tuesday receiving a postmarket surveillance study order from the U.S. Food and Drug Administration. TMJ Medical is one of three medical device manufacturers approved to market temporomandibular joint (TMJ) implants in the United States. Each manufacturer received the same FDA order.

10 Feb 2011

BioCryst reports net loss of $9.1M for fourth quarter 2010 vs. $15.2M net income for fourth quarter 2009

BioCryst Pharmaceuticals, Inc. announced financial results for the fourth quarter and full year ended December 31, 2010.

10 Feb 2011

TGMC installs third Toshiba Infinix DP-i system with Next Generation Advanced Image Processing

As a nationally recognized healthcare organization, home to one of the most advanced vascular interventional practices in the country, Terrebonne General Medical Center (TGMC) handles approximately 3,300 cath lab patients annually. Patients from all over the country come to TGMC for interventional treatment for conditions associated with cardiovascular disease (CVD) and peripheral vascular disease (PVD), including limb ischemia.

10 Feb 2011

Vical 2010 net loss increases to $30.4 million

Vical Incorporated today reported financial results for the year ended December 31, 2010. Vical had cash and investments of approximately $61 million at year-end 2010. The company received approximately $37 million of net proceeds from the sale of equity securities during 2010.

10 Feb 2011

Women with high folic acid levels may impact child's risk of developing asthma

Recent Norwegian research suggests that there may be a connection between high levels of folic acid in pregnant mothers and the development of asthma in their children. However, the researchers stress that pregnant women should continue to take folic acid supplements.

10 Feb 2011

Alexion fourth quarter net product sales of Soliris increases to $156.0 million

Alexion Pharmaceuticals, Inc. today announced financial results for the quarter and year ended December 31, 2010. For the three months ended December 31, 2010, Alexion Pharmaceuticals, Inc. reported net product sales of Soliris® (eculizumab) of $156.0 million, reflecting strong additions of new patients, compared to $110.6 million for the same period in 2009.

10 Feb 2011

Research News and Research

House Republicans unveil partial list of budget cuts, advance plan to offer amendments to 'defund' health law

New model of dementia care reduces emergency department visits, hospitalizations

Medivir initiates phase 1a clinical trial of TMC649128 for chronic HCV infection

College health plans must comply with health law's 'central provisions'

Global Health Consortium to support development of vaccines to control dengue fever

Genta initiates new Phase 2 clinical trial of tesetaxel in patients with advanced prostate cancer

Guide designed to help hospitals reduce variation in care

Researchers find significant association between childhood physical abuses, peptic ulcers

Analyst offers prediction about Medicare advantage plans

NeoGenomics fourth quarter revenue increases 12% to $8.8 million

First Edition: February 10, 2011

Momenta reports fourth quarter 2010 net income of $36.3M vs. $14.7M net loss for fourth quarter 2009

Full genetic blueprint of multiple prostate tumors laid bare

LabCorp fourth quarter net earnings decrease to $131.8 million

TMJ Medical receives FDA postmarket surveillance study order

BioCryst reports net loss of $9.1M for fourth quarter 2010 vs. $15.2M net income for fourth quarter 2009

TGMC installs third Toshiba Infinix DP-i system with Next Generation Advanced Image Processing

Vical 2010 net loss increases to $30.4 million

Women with high folic acid levels may impact child's risk of developing asthma

Alexion fourth quarter net product sales of Soliris increases to $156.0 million

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News